[Which is the strategy? The latest in the use of antiretrovirals].
Agosto
M
M
National Minority AIDS Council, Washington, DC.
D000998:Antiviral Agents / Q000138:chemical synthesis / Q000627:therapeutic use*; D016049:Didanosine / Q000138:chemical synthesis / Q000627:therapeutic use; D015195:Drug Design; D006678:HIV / Q000187:drug effects / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000138:chemical synthesis / Q000627:therapeutic use; D006801:Humans; D007546:Isoquinolines / Q000138:chemical synthesis / Q000627:therapeutic use; D011804:Quinolines / Q000138:chemical synthesis / Q000627:therapeutic use; D019438:Ritonavir; D019258:Saquinavir; D018119:Stavudine / Q000138:chemical synthesis / Q000627:therapeutic use; D013844:Thiazoles / Q000138:chemical synthesis / Q000627:therapeutic use; D014633:Valine / Q000138:chemical synthesis / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects; D016047:Zalcitabine / Q000138:chemical synthesis / Q000627:therapeutic use; D015215:Zidovudine / Q000138:chemical synthesis / Q000627:therapeutic use
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D013844:Thiazoles; D015215:Zidovudine; D016047:Zalcitabine; D018119:Stavudine; D014633:Valine; D016049:Didanosine; D019258:Saquinavir; D019438:Ritonavir